Because GLP-1 therapy reduces appetite, every smaller portion needs to deliver maximum nutrition
GLP-1 Receptor Agonists and Water Intake Suppression (SUNY Buffalo) - Research on the hypodipsic effects of GLP-1 receptor agonists in animal models National Kidney Foundation - Dehydration Signs and Prevention - Comprehensive resource on recognizing and preventing dehydration SeekPeptides members gain access to detailed protocols, dosing guides, and expert resources on managing every aspect of GLP-1 therapy, from hydration strategies to supplement stacks to injection techniques
Approved by the FDA under the name Egrifta for HIV-related lipodystrophy, it has demonstrated an increase in IGF-1, a 15.2% reduction in visceral fat, and an improvement in body composition in Phase 3 trials
10.1016/j.neures.2010.06.014 Neurosci
Some patients report developing aversions to previously enjoyed foods, particularly those high in fat or sugar, though individual experiences vary considerably